Received Mar 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | UNK | Y003145 | — |
No adverse event; HCP called to state that the patient received a third dose of PEDVAXHIB at 6 months of age. No symptomatic adverse events were reported. The AE onset date reflects the date of administration. HCP has declined to answer any further questions and has a; This spontaneous report was received from a Nurse and refers to a(n) 6-month-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 05-Dec-2024, the patient was vaccinated with the third dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB), lot #Y003145, expiration date: 12-Sep-2026, 0.5 mL (0.5ml/ series) (route of administration and anatomical location were not provided) for prophylaxis (extra dose administered). No additional adverse event reported (no adverse event).